Cargando…
Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged virus that causes coronavirus infectious disease 2019 (COVID-19). SARS-CoV-2 spike protein, like SARS-CoV-1, uses the angiotensin converting enzyme 2 (ACE2) as a cellular receptor to initiate infection. Compounds that...
Autores principales: | Day, Christopher J., Bailly, Benjamin, Guillon, Patrice, Dirr, Larissa, Jen, Freda E.-C., Spillings, Belinda L., Mak, Johnson, von Itzstein, Mark, Haselhorst, Thomas, Jennings, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092326/ https://www.ncbi.nlm.nih.gov/pubmed/33785634 http://dx.doi.org/10.1128/mBio.03681-20 |
Ejemplares similares
-
Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2
por: Pandey, Manisha, et al.
Publicado: (2021) -
An ace model for SARS-CoV-2 infection
por: Major, Jack, et al.
Publicado: (2020) -
Soluble ACE2 in SARS-CoV-2 infection
por: Allison, Susan
Publicado: (2021) -
ACE2: the molecular doorway to SARS-CoV-2
por: Medina-Enríquez, Miriam Marlene, et al.
Publicado: (2020) -
Fish ACE2 is not susceptible to SARS-CoV-2
por: Xie, Shi-Zhe, et al.
Publicado: (2022)